Proline or proline derivatives for the treatment of dementia
EP2384743A1
Siosomal formulation for intracellular delivery and targeting of therapeutic agents
BRPI0917644A2
carrier system for biological agents containing organo-silicon compounds and uses thereof.
EP1948196A2
Use of tetraorganosilicon compounds
DE102005053011A1
Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis
WO2006032268A1
Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton
US2008220083A1
Pharmaceutical Agent Comprising Blood Components <10 Kda And Their Use For Prophylaxis And Treatment Of Defects Of The Immune System
EP1796695A2
Pharmaceuticals agents comprising blood components <10 kda and their use for prophylaxis and treatment of defects of the immune system
KR20070026646A
Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
US2006067942A1
Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals
US2007265269A1
Water Soluble Esters of [N-(4-Amino-2-Butynyl)] with Anticancer Activity
ZA200605653B
Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
KR20060103530A
Proline derivatives used as pharmaceutical active ingredients for the treatment of tumors
AU2003298077A2
Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours
DE10359828A1
CHP gemcitabine combination agents and their use as antitumor agents, in particular anti-metastatic agents
DE10359829A1
Use of CHP as inhibitor of glutathione-S-transferases and collagen IV
AU2003286118A1
Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
EP1523984A1
Pharmaceutical composition comprising oxoplatin and salts thereof
